Cure ETF – Buy

Posted on | by Leon Hinde

CURE:AXW is under Algo Engine buy conditions and the current pullback provides another buying opportunity.

ETFS S&P Biotech ETF (ASX Code: CURE) offers investors exposure to U.S. biotechnology companies. These companies are engaged in research, development, manufacturing and/or marketing of products based on genetic analysis and genetic engineering.

.

U.S. Consumer Sentiment Plummets

Posted on | by Leon Hinde

U.S. consumer sentiment dropped sharply in early August to its lowest level in a decade, in a worrying sign for the economy as Americans gave faltering outlooks on everything from personal finances to inflation and employment, a survey showed. 

JB Hi Fi – Up 167%

Posted on | by Leon Hinde

JB Hi-Fi is under Algo Engine buy conditions and is a current holding in our ASX 100 model. The stock is up 126% since being added back in November 2017.

FY21 group sales rose 12% to $8.9 billion and profit jumped to $506 million, which was largely in line with consensus forecasts, however, the electronics retailer warned that the 2022 financial year has had a softer start.

Lendlease – Challenging Year

Posted on | by Leon Hinde

Lendlease has warned of a challenging year to come as COVID-19 puts a dampener on development and construction globally.

FY21 net profit after tax of $377 million was in line with the company’s guidance, largely due to divesting its loss-making engineering and services.

We expect to see an improvement in earnings towards the end of FY22.